DIFFERENTIAL SUSCEPTIBILITY OF TYPE-III ERYTHROCYTES OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA TO LYSIS MEDIATED BY COMPLEMENT AND PERFORIN

被引:11
作者
JIANG, S
PERSECHINI, PM
ROSSE, WF
PERUSSIA, B
YOUNG, JD
机构
[1] DUKE UNIV,MED CTR,DEPT MED,DIV HEMATOL ONCOL,DURHAM,NC 27710
[2] WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104
关键词
D O I
10.1016/0006-291X(89)91998-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:316 / 325
页数:10
相关论文
共 43 条
[1]   INTERACTION OF FC-RECEPTOR (CD16) LIGANDS INDUCES TRANSCRIPTION OF INTERLEUKIN-2 RECEPTOR (CD25) AND LYMPHOKINE GENES AND EXPRESSION OF THEIR PRODUCTS IN HUMAN NATURAL-KILLER CELLS [J].
ANEGON, I ;
CUTURI, MC ;
TRINCHIERI, G ;
PERUSSIA, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :452-472
[2]   RESISTANCE OF CLONED CYTOTOXIC LYMPHOCYTES-T TO CELL-MEDIATED CYTOTOXICITY [J].
BLAKELY, A ;
GORMAN, K ;
OSTERGAARD, H ;
SVOBODA, K ;
LIU, CC ;
YOUNG, JDE ;
CLARK, WR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :1070-1083
[3]  
CHOW FL, 1985, BLOOD, V66, P940
[4]  
CHOW FL, 1986, BLOOD, V67, P893
[5]   RELEASE OF DECAY-ACCELERATING FACTOR (DAF) FROM THE CELL-MEMBRANE BY PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-C (PIPLC) - SELECTIVE MODIFICATION OF A COMPLEMENT REGULATORY PROTEIN [J].
DAVITZ, MA ;
LOW, MG ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) :1150-1161
[6]  
HAMMER CH, 1981, J BIOL CHEM, V256, P3995
[7]   PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA TYPE-III - LACK OF AN ERYTHROCYTE-MEMBRANE PROTEIN RESTRICTING THE LYSIS BY C5B-9 [J].
HANSCH, GM ;
SCHONERMARK, S ;
ROELCKE, D .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (01) :7-12
[8]   HOMOLOGOUS SPECIES RESTRICTION IN LYSIS OF ERYTHROCYTES BY TERMINAL COMPLEMENT PROTEINS [J].
HANSCH, GM ;
HAMMER, CH ;
VANGURI, P ;
SHIN, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :5118-5121
[9]   MECHANISM OF LYMPHOCYTE-MEDIATED CYTO-TOXICITY [J].
HENKART, PA .
ANNUAL REVIEW OF IMMUNOLOGY, 1985, 3 :31-58
[10]  
HU VW, 1984, J IMMUNOL, V133, P2133